MBX Biosciences, Inc. MBX Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s accrued liabilities, current?
- MBX Biosciences, Inc. (MBX) reported accrued liabilities, current of $7.42M in Q1 2026.
- How has MBX Biosciences, Inc.'s accrued liabilities, current changed year-over-year?
- MBX Biosciences, Inc.'s accrued liabilities, current increased by 21.4% year-over-year, from $6.11M to $7.42M.
- What is the long-term trend for MBX Biosciences, Inc.'s accrued liabilities, current?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s accrued liabilities, current has grown at a 127.7% compound annual growth rate (CAGR), from $2.38M to $12.35M.